CNBX Pharmaceuticals Inc. (CNBX) Cash from Investing Activities (2014 - 2024)

CNBX Pharmaceuticals (CNBX) has 10 years of Cash from Investing Activities data on file, last reported at $94673.0 in Q2 2024.

• Quarterly Cash from Investing Activities changed N/A year-over-year to $94673.0 in Q2 2024, while the trailing twelve-month figure through Feb 2025 was $94673.0 (up 403.47% YoY) and the FY2024 annual result came in at $113477.0, up 359.38% from the prior year.
• Cash from Investing Activities improved to $94673.0 in Q2 2024, from $20000.0 in the prior quarter.
• In the past five years, Cash from Investing Activities ranged from a high of $1.1 million in Q3 2020 to a low of -$1196.0 in Q4 2023.
• A 5-year average of $298178.9 and a median of $25742.0 in 2022 frame the typical range for Cash from Investing Activities.
• The widest YoY moves for Cash from Investing Activities: up 233.92% in 2020, down 100.12% in 2020.
• Tracing CNBX's Cash from Investing Activities over 5 years: stood at -$943.0 in 2020, then soared by 45.6% to -$513.0 in 2021, then jumped by 5117.93% to $25742.0 in 2022, then slumped by 104.65% to -$1196.0 in 2023, then jumped by 8015.8% to $94673.0 in 2024.
• The last three Cash from Investing Activities figures came in at $94673.0 (Q2 2024), $20000.0 (Q1 2024), and -$1196.0 (Q4 2023), per Business Quant data.